Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion suggests a possible link between iron levels and hair health in women, recommending further research on iron supplementation for hair loss.

Women with PCOS have a higher risk of severe COVID-19 due to related health issues.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

Social media data can help track and predict COVID-19 symptoms and trends.

Cysteine helps maintain keratin production in skin cells even when iron is low.

Microneedle made of iron oxide and PVA helps hair regrowth in alopecia treatment.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Hispanics in Northern Nevada had more COVID-19 cases but lower mortality than non-Hispanics.

Certain plasma proteins and genes are linked to obstructive sleep apnea, suggesting potential new treatments.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Older adults in Vietnam often experience hair loss after COVID-19, especially women, singles, and those hospitalized.

Hispanic individuals in Northern Nevada were more affected by COVID-19 but had lower mortality rates than non-Hispanics.

Certain Dibenzo derivatives may help treat prostate cancer.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

Women with conditions like PCOS may have a higher risk of COVID-19, but treatments like isotretinoin could help those with acne.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Covid-19 can cause skin and oral symptoms, like taste changes, which help in detection and management.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

Proxalutamide significantly lowered hospitalization rates in women with mild-to-moderate COVID-19.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

Combining iron supplements with physiotherapy could better treat women's hair loss linked to iron deficiency.

Some vitamins and minerals are important for preventing hair loss, but treating hair loss with them without a known deficiency is not proven effective.